Cargando…

Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort

OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus d...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosn, Jade, Bachelet, Delphine, Livrozet, Marine, Cervantes-Gonzalez, Minerva, Poissy, Julien, Goehringer, François, Gandonniere, Charlotte Salmon, Maillet, Mylène, Bani-Sadr, Firouzé, Martin-Blondel, Guillaume, Tattevin, Pierre, Launay, Odile, Surgers, Laure, Dudoignon, Emmanuel, Liegeon, Geoffroy, Zucman, David, Joseph, Cédric, Senneville, Eric, Yelnik, Cécile, Roger, Pierre-Marie, Faure, Karine, Gousseff, Marie, Cabié, André, Duval, Xavier, Chirouze, Catherine, Laouénan, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523945/
https://www.ncbi.nlm.nih.gov/pubmed/36191847
http://dx.doi.org/10.1016/j.cmi.2022.08.028
_version_ 1784800400483811328
author Ghosn, Jade
Bachelet, Delphine
Livrozet, Marine
Cervantes-Gonzalez, Minerva
Poissy, Julien
Goehringer, François
Gandonniere, Charlotte Salmon
Maillet, Mylène
Bani-Sadr, Firouzé
Martin-Blondel, Guillaume
Tattevin, Pierre
Launay, Odile
Surgers, Laure
Dudoignon, Emmanuel
Liegeon, Geoffroy
Zucman, David
Joseph, Cédric
Senneville, Eric
Yelnik, Cécile
Roger, Pierre-Marie
Faure, Karine
Gousseff, Marie
Cabié, André
Duval, Xavier
Chirouze, Catherine
Laouénan, Cédric
author_facet Ghosn, Jade
Bachelet, Delphine
Livrozet, Marine
Cervantes-Gonzalez, Minerva
Poissy, Julien
Goehringer, François
Gandonniere, Charlotte Salmon
Maillet, Mylène
Bani-Sadr, Firouzé
Martin-Blondel, Guillaume
Tattevin, Pierre
Launay, Odile
Surgers, Laure
Dudoignon, Emmanuel
Liegeon, Geoffroy
Zucman, David
Joseph, Cédric
Senneville, Eric
Yelnik, Cécile
Roger, Pierre-Marie
Faure, Karine
Gousseff, Marie
Cabié, André
Duval, Xavier
Chirouze, Catherine
Laouénan, Cédric
author_sort Ghosn, Jade
collection PubMed
description OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. METHODS: Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. RESULTS: We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). CONCLUSIONS: One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men.
format Online
Article
Text
id pubmed-9523945
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-95239452022-09-30 Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort Ghosn, Jade Bachelet, Delphine Livrozet, Marine Cervantes-Gonzalez, Minerva Poissy, Julien Goehringer, François Gandonniere, Charlotte Salmon Maillet, Mylène Bani-Sadr, Firouzé Martin-Blondel, Guillaume Tattevin, Pierre Launay, Odile Surgers, Laure Dudoignon, Emmanuel Liegeon, Geoffroy Zucman, David Joseph, Cédric Senneville, Eric Yelnik, Cécile Roger, Pierre-Marie Faure, Karine Gousseff, Marie Cabié, André Duval, Xavier Chirouze, Catherine Laouénan, Cédric Clin Microbiol Infect Original Article OBJECTIVES: Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. METHODS: Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. RESULTS: We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). CONCLUSIONS: One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men. European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-02 2022-09-30 /pmc/articles/PMC9523945/ /pubmed/36191847 http://dx.doi.org/10.1016/j.cmi.2022.08.028 Text en © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Ghosn, Jade
Bachelet, Delphine
Livrozet, Marine
Cervantes-Gonzalez, Minerva
Poissy, Julien
Goehringer, François
Gandonniere, Charlotte Salmon
Maillet, Mylène
Bani-Sadr, Firouzé
Martin-Blondel, Guillaume
Tattevin, Pierre
Launay, Odile
Surgers, Laure
Dudoignon, Emmanuel
Liegeon, Geoffroy
Zucman, David
Joseph, Cédric
Senneville, Eric
Yelnik, Cécile
Roger, Pierre-Marie
Faure, Karine
Gousseff, Marie
Cabié, André
Duval, Xavier
Chirouze, Catherine
Laouénan, Cédric
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title_full Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title_fullStr Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title_full_unstemmed Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title_short Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
title_sort prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523945/
https://www.ncbi.nlm.nih.gov/pubmed/36191847
http://dx.doi.org/10.1016/j.cmi.2022.08.028
work_keys_str_mv AT ghosnjade prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT bacheletdelphine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT livrozetmarine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT cervantesgonzalezminerva prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT poissyjulien prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT goehringerfrancois prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT gandonnierecharlottesalmon prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT mailletmylene prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT banisadrfirouze prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT martinblondelguillaume prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT tattevinpierre prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT launayodile prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT surgerslaure prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT dudoignonemmanuel prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT liegeongeoffroy prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT zucmandavid prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT josephcedric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT sennevilleeric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT yelnikcecile prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT rogerpierremarie prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT faurekarine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT gousseffmarie prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT cabieandre prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT duvalxavier prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT chirouzecatherine prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT laouenancedric prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort
AT prevalenceofpostacutecoronavirusdisease2019symptomstwelvemonthsafterhospitalizationinparticipantsretainedinfollowupanalysesstratifiedbygenderfromalargeprospectivecohort